Sputum and plasma endothelin-1 levels in exacerbations of chronic obstructive pulmonary disease
about
Effects of inhaled corticosteroids on sputum cell counts in stable chronic obstructive pulmonary disease: a systematic review and a meta-analysisAdhesion molecules, endothelin-1 and lung function in seven population-based cohorts.Cigarette smoke induces persisting increases of vasoactive mediators in pulmonary arteries.ETB receptor polymorphism is associated with airway obstruction.Exhaled and arterial levels of endothelin-1 are increased and correlate with pulmonary systolic pressure in COPD with pulmonary hypertensionCytokine inhibition in the treatment of COPD.Significance of the microbiome in chronic obstructive pulmonary disease.Novel insights into the aetiology and pathophysiology of increased airway inflammation during COPD exacerbations.Chronic obstructive pulmonary disease. 5: systemic effects of COPDChronic obstructive pulmonary disease . 6: The aetiology of exacerbations of chronic obstructive pulmonary diseaseSystemic anti-inflammatory mediators in COPD: increase in soluble interleukin 1 receptor II during treatment of exacerbations.Increased leukotriene B4 and 8-isoprostane in exhaled breath condensate of patients with exacerbations of COPD.Pulmonary hypertension in chronic obstructive pulmonary disease: current theories of pathogenesis and their implications for treatment.A Systematic Review of Diagnostic Biomarkers of COPD Exacerbation.Role of infection and antimicrobial therapy in acute exacerbations of chronic obstructive pulmonary disease.COPD exacerbations . 2: aetiologyOxidative and Nitrosative Stress and Histone Deacetylase-2 Activity in Exacerbations of COPD.Outcome measures for COPD treatments: a critical evaluation.Sputum endothelin-1 level is associated with active pulmonary tuberculosis and effectiveness of anti-tuberculosis chemotherapy.Characterization of endothelin receptors in the peripheral lung tissues of horses unaffected and affected with recurrent airway obstruction.Pulmonary hypertension associated with COPD.Pathogen-directed therapy in acute exacerbations of chronic obstructive pulmonary disease.Novel relationships of markers of monocyte activation and endothelial dysfunction with pulmonary dysfunction in HIV-infected persons.Update in chronic obstructive pulmonary disease 2007.Change in inflammation in out-patient COPD patients from stable phase to a subsequent exacerbationAirways inflammation and treatment during acute exacerbations of COPD.Role of macrolide therapy in chronic obstructive pulmonary disease.Pharmacological and genetic reappraisals of protease and oxidative stress pathways in a mouse model of obstructive lung diseases.Influenza A virus infection and cigarette smoke impair bronchodilator responsiveness to β-adrenoceptor agonists in mouse lungLymphocyte subsets in experimental rhinovirus infection in chronic obstructive pulmonary disease.Pulmonary biomarkers in COPD exacerbations: a systematic review.Respiratory damage in children exposed to urban pollution.Evaluation of plasma leptin, tumor necrosis factor-α, and prealbumin as prognostic biomarkers during clinical recovery from acute exacerbations of chronic obstructive pulmonary disease.In vitro sensitization of human bronchus by beta2-adrenergic agonists.Effects of endothelin-1 on epithelial ion transport in human airways.beta2-Adrenoceptor agonist modulates endothelin-1 receptors in human isolated bronchi.Leg blood flow is impaired during small muscle mass exercise in patients with COPD.The evaluation of retinal and choroidal structural changes by optical coherence tomography in patients with chronic obstructive pulmonary disease.Delayed resolution of inflammatory response compared with clinical recovery in patients with acute exacerbations of chronic obstructive pulmonary disease.Endothelin-1 downregulates angiotensin-converting enzyme-2 expression in human bronchial epithelial cells.
P2860
Q24797765-A7E82C5B-AB6E-4D1D-9644-960EDFE9DEE4Q30415316-401A1EF2-DA7C-4B53-B728-C7618F88C7DFQ31090056-8B61D9BE-2FC4-426C-8081-D359E03E08BFQ33283253-33F0F01C-183B-4F85-8616-3C06FE543D63Q33372442-0EA3FB03-7719-4280-9CD0-B81AB0EA2A6EQ33568552-3F3B7173-ECBD-4318-8977-231E59CC55AAQ33817613-71424C47-E8A1-4919-9477-988F92E3E03CQ34684239-3E8E6B4B-C8DF-4ACA-86B2-6BF3028DE3F7Q35009945-710E2A31-2B3C-4E31-B215-6E861B3A8281Q35038218-CCA895A0-BF8F-44BE-BDF5-31EF46970170Q35534719-D93FD032-5CDC-43E8-93A1-097E9A404279Q35535840-540F1142-DCB0-4171-8906-809DBA709050Q35537798-94993AE1-BAB2-46B1-B574-B2336DCFA1F4Q36081606-DE43C5B8-B681-4A65-98E0-C948BC141AE8Q36379352-06CA4603-9874-4B31-9E10-9A5EFA6E8C3AQ36414253-EF328F8D-A876-4192-87E1-873FD1034197Q36426923-A96140C4-E31A-4AF6-9D13-4FAE66B79251Q36602287-1D730426-1065-48EA-A4B5-358A66FA7A3DQ36640587-7C35C789-A392-46D6-89F6-86A47A6C008CQ36742385-1421E8E2-8390-4599-B0F7-3422017037F4Q36859451-15B87965-6538-4E89-B6B5-2FDC6CE46676Q37029615-0DAE0C9A-1D54-4D9B-AF03-1D5A3C08BE20Q37102014-972BA044-68CB-4A37-9CC9-1AC11613AA0DQ37129292-BDDE3E9C-54EA-4ADA-B4A0-BDA06F7A207CQ37168345-6F334434-2D03-421B-AAC2-98C221C7186AQ37237665-C27D28A7-90F0-4B30-B299-529D1F9B34E6Q37319950-D71A7058-5AA1-49E2-AF9F-7687E538F2F4Q37508534-F892CDFC-65D9-43A9-937F-BB82BEBE63D1Q37583861-BAB26C93-1E4D-487A-878D-2AA9666D2EFAQ37672038-C9811F14-0AED-4C23-9E27-3039883FF1E5Q38154291-468B5809-1183-4C47-86F2-51AD491BB25AQ39653450-85A88035-0312-4507-A46C-B4B1E2DD2035Q41958409-FDA16C79-0DDA-43B2-A949-6E9156830616Q44176962-0D06B951-7201-4DF6-A611-BAA17EF906B6Q44355172-89979E4D-B143-42B5-ACC6-DCF71744A85AQ46844432-C159A933-04F1-4A4E-84B1-5023228F60D3Q47773094-15366DC2-8EF1-44AD-A666-D9DCFA9795B0Q47909186-D83C38C3-BDCF-4967-85E0-489687CB6BC6Q48235233-FEBF88AD-0952-4347-ACE4-38694EF79E73Q50921360-22498A27-B7A7-498D-A199-3DD216360FA2
P2860
Sputum and plasma endothelin-1 levels in exacerbations of chronic obstructive pulmonary disease
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2001
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Sputum and plasma endothelin-1 ...... obstructive pulmonary disease
@en
Sputum and plasma endothelin-1 ...... obstructive pulmonary disease.
@nl
type
label
Sputum and plasma endothelin-1 ...... obstructive pulmonary disease
@en
Sputum and plasma endothelin-1 ...... obstructive pulmonary disease.
@nl
prefLabel
Sputum and plasma endothelin-1 ...... obstructive pulmonary disease
@en
Sputum and plasma endothelin-1 ...... obstructive pulmonary disease.
@nl
P2093
P2860
P356
P1433
P1476
Sputum and plasma endothelin-1 ...... obstructive pulmonary disease
@en
P2093
Jeffries DJ
Sapsford RJ
Seemungal TA
Wedzicha JA
P2860
P356
10.1136/THORAX.56.1.30
P407
P577
2001-01-01T00:00:00Z